Merger Announced
Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger
US$2.4bn consideration
Announced 21 Sep 2026
Advisers
ITM Isotope Technologies Munich SE
Target
- Financial adviser
- Legal adviser
Telix Pharmaceuticals
Acquirer
- Financial adviser
- Legal adviser
- Target
- ITM Isotope Technologies Munich SE
- Acquirer
- Telix Pharmaceuticals
- Structure
- Private sale
- Sector
- Biotech and pharmaceuticals
In the league tables
Similar deals
- BGH Capital acquisition of Aspen Pharmacare Asia Pacific business Jun 2026 · A$2.4bn · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Health Aug 2025 · A$1.6bn · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Global Enterprises Aug 2025 · A$7bn · Biotech and pharmaceuticals
- Avista Healthcare Partners acquisition of Mayne Pharma Group Feb 2025 · A$672m · Biotech and pharmaceuticals
- TPG acquisition of Agilex Biolabs Sep 2026 · A$160m · Biotech and pharmaceuticals
Sources
- 21 Sep 2026 Telix and ITM Join Forces to Create Radiopharma Powerhouse ASX
- 22 Sep 2026 Herbert Smith Freehills Kramer Advises Telix Pharmaceuticals Limited On Its Transformational Merger With ITM Isotope Technologies Munich SE mondaq.com
- 7 Oct 2026 Telix Pharmaceuticals to Acquire ITM Isotope Technologies Munich in Strategic Merger Worth Up to US$2.35 Billion globallegalchronicle.com